Seven of the largest MA payers reported Q1 2026. Read across the calls and the message is unambiguous. Here is what each one signaled, what they said collectively, and what it means for your AEP 2027 positioning
Alignment Healthcare’s (ALHC) Q1 2026 results are the sharpest counterpoint to the national payer narrative this earnings season.
Network adequacy is no longer a competitive position in Medicare Advantage. Here is how leading health plans are moving from compliance to sculpting ahead of 2027 bids.
Alignment Healthcare’s (ALHC) Q1 2026 results are the sharpest counterpoint to the national payer narrative this earnings season.
The most surprising finding in Elevance Health’s Q1 2026 report is not the 16% adjusted EPS beat—it is the hidden anatomy of that beat. Of the $12.58 adjusted EPS.
Centene’s Q1 2026 results landed roughly $0.50 ahead of its own internal expectations, with adjusted EPS of $3.37 and a 58% beat over Street consensus.
Now that bid submissions are in, this exclusive BCBS-focused session explored how top plans are stress-testing their final bids, validating enrollment assumptions, and preparing for strategic AEP execution.
A deep dive into the 2023 AEP enrollment data, including year-over-year trends, regional variations, and emerging markets.
In this webinar we assess the competitive rank of each network in a market, exploit opportunities, and identify the most influential physicians and hospitals.
In this webinar we analyze the 2022 AEP enrollment data as we dive into year-over-year trends, regional variations, emerging markets, and much more.
We focus on the application of xAI in healthcare marketing, with emphasis on how Payers and Providers can measure the impact of individual variables to increase marketing ROI.
We discuss how Explainable AI (xAI) models are the foundation of an analytical revolution in healthcare marketing.
